2025³â 08¿ù 05ÀÏ È­¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92443°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

¡®¹®ÇÐÀ¸·Î ¸¸µå´Â ¸¶À½ÀÇ Æò¾È, ±Ý°­À§Å©¡¯ °³ÃÖ

»ó¼³ üÇèºÎÅÍ »ê»ç Äܼ­Æ®, ¸í»çÃÊû¹ýȸ±îÁö¡¦ ½ÅÁß³âÃþ ¸ÂÃã ÇÁ·Î±×·¥
º¸ÇöÇà¿øÀ» ½ÇõÇÏ´Â Àü¹ýµµ·® ´ëÇѺұ³Á¶°èÁ¾ ±Ý°­Á¤»ç(ÁÖÁö °¡¼·½º´Ô)°¡ 8¿ù 1ÀϺÎÅÍ 10¿ù 31ÀϱîÁö 3°³¿ù°£ ¹®ÇÐÀ» ÅëÇÑ ¸¶À½ Ä¡À¯ ÇÁ·Î±×·¥ ‘Á¦3ȸ ¹®ÇÐÀ¸·Î ¸¸µå´Â ¸¶À½ÀÇ Æò¾È, ±Ý°­À§Å©(ÁÖÃÖ ¹× ÁÖ°ü: ´ëÇѺұ³Á¶°èÁ¾ ±Ý°­Á¤»ç, ÈÄ¿ø: °æ±âµµ)’¸¦ ÁøÇàÇÑ´Ù°í 30ÀÏ ¹àÇû´Ù. °æ±âµµ ±¤¸í½Ã¿¡ À§Ä¡ÇÑ ±Ý°­Á¤»ç´Â ȸÁÖ½º´ÔÀ̽Šº®¾Ï(ÁöÈ«)½º´Ô°ú Àç°¡ºÒÀÚµéÀÇ ¿ø·ÂÀ¸·Î ºÒ±â 2535³â(1991³â) 1¿ù °³¿øÇÑ ½ÅÇà °øµ¿Ã¼´Ù. È£¹ý¹ýȸ ¹× ÀÏ¿ä¹ýȸ µî ´Ù¾çÇÑ Á¤±â¹ýȸ¸¦ ºñ·ÔÇØ ‘³» ¸¶À½ÀÇ Çູ¿©Çà(1¹Ú2ÀÏ Ã¼ÇèÇü)&rs ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
´ëÇÑÀü¼±, ±¹³» ÃÖÃÊÀÇ ÃÊ-ÀåÁ¶Àå Àü·Â¸Á ÇÁ·ÎÁ§Æ® ¼öÁÖ (2024-11-26)
µ¿¾ÆÁ¦¾à, Áõ»ó ¸ÂÃ㠴ܰ躰 Àΰø´«¹° ¾ÆÀÌ¿ÀÄð Ãâ½Ã (2024-06-23)
¡®K-POP ¼­¿ï½ÃƼ¹ö½º¡¯·Î K-Trip Ȱ¼ºÈ­ À̲ö´Ù (2024-07-31)
Kirin¡¯s Electric Salt Spoon Shines At CES Innovation Awards... (2024-12-30)
ÇÁ¸®¹Ì¾ö ´Ùȸ¿ë ÄÅ ¼­ºñ½º ¡®¾Æ¶õÅס¯ Ãâ½Ã (2024-09-20)
ÀÌû¾Æ, N21 Çö´ë¹éÈ­Á¡ ¹«¿ª¼¾ÅÍÁ¡ ¸ÅÀå ¹æ¹® (2024-09-20)
Çѱ¹ ÁöµµÀÚ°¡ À̲ô´Â ±Û·Î¹ú ºÀ»ç´Üü ·ÎŸ¸® 140¸¸ ȸ¿ø (2024-09-20)
Àå¼ödzµ­ÀÌ ³¯°¹Áþ ¸ð¹æÇÑ ºñÇà ·Îº¿ °³¹ß (2024-08-09)
¹è¿ì °íÇѹΠ¡®Àü,¶õ¡¯¿¡¼­ Å뿪»ç ¡®¼ÒÀÌÄ¡·Î¡¯·Î °­ÇÑ Àλó (2024-10-28)
Çö´ë¿¤¸®º£ÀÌÅÍ, ¾÷°è ÃÖÃÊ ¡®°ø°£¾ÈÀüÀÎÁõ¡¯ ȹµæ (2024-10-07)
Your 10 Must-do Chinese New Year Activities in Hong Kong (2025-01-16)
June Yang Appointed to MSCI Inc. Board of Directors (2024-12-26)
Á¤½Å°Ç°­ µ¹º½ Èú¸µ ÄÜÅÙÃ÷ ¡®¸¶Àεå½ÃƼ¡¯ ¾Û ¸®´º¾ó Ãâ½Ã (2024-12-05)
REX and Tuttle Expand T-REX ETF Suite with 2X Leveraged ETFs... (2025-03-16)
Åõ½æÇ÷¹À̽º, º¹ÀÚ ÇÁ¶óÆä µî º½ ½ÃÁð ÇÑÁ¤ À½·á Ãâ½Ã (2024-03-24)
'½Å¶û¼ö¾÷¡¯ ¿¡³ì, ¡®À̺¸¿µ ´àÀº²Ã¡¯ ÀÇ»ç¿Í Á¤½Ä µ¥ÀÌÆ® (2024-09-25)
ìí ³ª³ë Å©±â °áÁ¤ ÀÔÀÚ ¹é±Ý ¼ÒÀç Á¦Á¶ ±â¼ú °³¹ß (2024-11-27)
Á¤Á¶È¿¹®È­Á¦ ¡®°¨»çÇØÈ¿ ³ë·¡ÀÚ¶û¡¯ °³ÃÖ (2024-08-31)
Æø½º¹Ù°ÕÄÚ¸®¾Æ, Àü±âÂ÷ Ưº° ¹«»ó ¾ÈÀüÁ¡°Ë ½ÃÇà (2024-09-21)
¿©¸§Ã¶ ³¯¾¾, °í¾îÅØ½º ¸ðÀÚ·Î ÇÑ ¹ø¿¡ ´ëºñÇÏÀÚ (2024-08-06)
¿¡À̼ö½º, Arm ±â¹Ý SBCÀÎ ¡®ASUS IoT Tinker Board 3N¡¯ (2023-08-28)
Çб³ ¹Û û¼Ò³âµéÀÇ ÀھƽÇÇö ÇÁ·ÎÁ§Æ® ¡®³ª¿Í ³Ê¸¦ ¸¶ÁÖÇÏ´Ù¡¯ (2024-08-27)
Toshiba Releases Gate Driver IC for Automotive Brushed DC Mo... (2025-03-29)
Bynder Showcases Its New and Expanded AI Capabilities at NRF... (2025-01-21)
¡®ÀüÇö¹«°èȹ2¡¯, ÀüÇö¹« ÃÖ¾Ö ¼ø´ñ±¹Áý µåµð¾î °ø°³ (2024-10-25)
       [ÀÌÀü][1]....[447][448][449][450][451][452][453][454][455]...[3698][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..